POLMED SA Article 56 (1) (2) of the Law on Public Offering - current and interim information
Disposal of significant value assets by Polmed S.A. to its subsidiary Polmed Zdrowie Sp. z o.o.
Report content:The Board of Directors of POLMED S.A. with its registered office in Starogard Gdański makes public that the Issuer disposed of significant value assets within its Capital Group in the form of 4,999 (four thousand nine hundred ninety-nine) shares in its subsidiary - POLMED Development Sp. z o.o. with its registered office in Starogard Gdański, with a nominal value of PLN 1,000.00 (one thousand Polish zlotys) each and the total nominal value of PLN 4,999,000.00 (four million nine hundred and ninety-nine thousand Polish zlotys), which represent 49.99% of the shares and 49.99 % of voting rights in POLMED Development Sp. z o.o. The book value of the disposed assets in the Issuer's accounting books was also PLN 4,999,000.00 (four million nine hundred and ninety-nine thousand Polish zlotys), and they served as a long-term investment of capital. Prior to the transaction, the Issuer owned 100% of the shares and 100% of votes in POLMED Development Sp. z o.o.
The disposal of shares took place on behalf of another subsidiary of the Issuer - POLMED Zdrowie Sp. z o.o. with its registered office in Starogard Gdański. The disposal of shares was carried out as paying-up share capital increase of Polmed Zdrowie Sp. z o.o. The share capital of POLMED Zdrowie Sp. z o.o. was increased by the amount of PLN 166,500.00 (one hundred sixty-six thousand five hundred Polish zlotys) through new 333 (three hundred thirty-three) shares with a nominal value of PLN 500 (five hundred Polish zlotys) each. The shares taken up by POLMED S.A. were covered with a contribution in kind in the form of 4,999 (four thousand nine hundred ninety-nine) shares in POLMED Development Sp. z o.o. The value of transferring of ownership of 4,999 shares in POLMED Development Sp. z o.o. from POLMED S.A. to POLMED Zdrowie Sp. z o.o. amounts to PLN
5,093,981.00 (five million ninety-three thousand nine hundred and eighty-one Polish zlotys) - taking into account their market value.
Currently, after submitting a proper request in this regard, the Issuer is expecting to obtain a court decision on registration of the share capital increase in POLMED Zdrowie Sp. z o.o. with its registered office in Starogard Gdański. Immediately - after the receipt of the order - the Issuer will provide another report in this regard.
POLMED Zdrowie Sp. z o.o. is a subsidiary of the Issuer. After the share capital increase of POLMED Zdrowie Sp. z o.o, POLMED S.A. will hold 99.7% of shares and 99.7% of the votes in that company. The President of the Management Board of POLMED Zdrowie Sp. z o.o. is Mr. Mariusz Szulc, who is also Commercial Director in POLMED S.A.
The abovementioned assets are considered as assets of significant value due to the fact that they represent at least 10% of the equity of the Issuer.
The Decree of the Minister of Finance of 19 February 2009 on current and periodic information provided by issuers of securities and the conditions for recognition as equivalent information required by the law of a non-Member State - §5 (1) (1)
Date | Name | Position/function | Signature |
RADOSŁAW SZUBERT | President of the Board of Directors | ||
ROMUALD MAGDOŃ | Vice-President of the Board of Directors |
Polmed SA issued this content on 2015-12-17 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2015-12-28 10:30:31 UTC
Original Document: http://www.inwestor.polmed.pl/pub/en/uploaddocs/current-report-no.-32-2015.1451298140.pdf
